AMEND wishes to support research and is provides grants when funds allow to enable medical researchers to supplement an existing project or pump-prime new research ideas. Applicants must be registered members of AMEND and the successful projects must be specifically directed to the study of endocrine tumours, within the context of the Charity’s remit (MEN1, MEN2, MEN3, SDHx, ACC, spMTC). Awards are only available to projects carried out within the United Kingdom and Eire. Each project grant is usually worth up to £10,000, although larger amounts have been awarded. Commonly, up to 3 project grants are available annually, although this can vary according to surplus funds available.
2021 Award Round Now Open!
The 2021 Round deadline is 31 August (due to COVID-19)
(Total Fund = £40,000 including x2 grants of £10,000 for MEN1 Research)
The Nick Fayers Award for MEN1 Research forms part of the annual grants programme. It was set up in memory of the late Nick Fayers who had MEN1, and whose friends and family raised £100,000 for AMEND in 2018/19. These grants are available until further notice for one or more research projects directly related to MEN1 tumours.
The John Pettit Award for MEN1 Research forms part of the annual grants programme for 2021. It was set up in memory of the late John Pettit who had MEN1, and whose friends and family raised £10,000 for AMEND in 2020. This grant is available for 2021 only.
For further information and criteria, please view the application form:
AMEND Research Fund Application Form
NIHR Non-Commercial Partnership
AMEND is a National Institute for Health Research (NIHR) non-commercial Partner. This means the studies that we fund may be eligible to access the NIHR Study Support Service which is provided by the NIHR Clinical Research Network. The NIHR Clinical Research Network can now support health and social care research taking place in non-NHS settings, such as studies running in care homes or hospices, or public health research taking place in schools and other community settings. Read the full policy: Eligibility Criteria for NIHR Clinical Research Network Support.
In partnership with your local R&D office, we encourage you to involve your local NIHR Clinical Research Network team in discussions as early as possible when planning your study. This will enable you to fully benefit from the support available through the NIHR Study Support Service. To find out more, please visit: www.nihr.ac.uk/study-support-service
If your study involves NHS sites in England you will need to apply for Health Research Authority Approval. For guidance on submitting an application please visit: www.hra.nhs.uk.
Current and Past Award(s)
- 2020 Awards: 2 projects have so far been funded in 2020 (MEN1, Phaeo/Para). Click here to view the project outlines.
- 2019 Awards: 4 projects have been funded in 2019 (MEN1, SDH, Pheo/Para, ACC) totalling £28,482.47. Click here to view the projects.
- 2015 Awards: 4 projects have been funded in 2015, including 3 MTC projects from a special fund for 2015. Click here to view the projects which total £50,000.
- 2014 Award: Improved genetic diagnosis of MEN1 by next generation sequencing of the entire MEN1 gene. Ms Martina Owens, BSc, MA, Clinical Scientist, The Royal Devon & Exeter Molecular Genetics Centre. £9,910
- 2013 Award: Occurrence of microRNAs in the plasma of MEN1 patients and their feasibility as biomarkers. Ms Kate Lines, BSc (Hons), PhD, Postdoctoral Research Assistant (Endocrinology), OCDEM, Oxford. £9,994
- 2012 Award: Prophylactic Thyroidectomy in Children with MEN2 in the UK. Mr Francesco Prete, MD, PhD, Senior Clinical Fellow, Department of Endocrine Surgery, University College and Great Ormond Street Hospitals. £5,050